| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Attenuated recombinant Yersinia as live oral vaccine carrier to protect against amoebiasis
|
Lotter, Hannelore
|
|
2008
|
|
1-2 |
p. 79-86
8 p.
|
artikel
|
| 2 |
A vaccine against Helicobacter pylori: Towards understanding the mechanism of protection
|
Aebischer, Toni
|
|
2008
|
|
1-2 |
p. 161-168
8 p.
|
artikel
|
| 3 |
CpG oligonucleotides as adjuvant in therapeutic vaccines against parasitic infections
|
Zimmermann, Stefan
|
|
2008
|
|
1-2 |
p. 39-44
6 p.
|
artikel
|
| 4 |
Development of a tripartite vector system for live oral immunization using a Gram-negative probiotic carrier
|
Buddenborg, Christian
|
|
2008
|
|
1-2 |
p. 105-114
10 p.
|
artikel
|
| 5 |
Development of hepatitis B virus capsids into a whole-chain protein antigen display platform: New particulate Lyme disease vaccines
|
Nassal, Michael
|
|
2008
|
|
1-2 |
p. 135-142
8 p.
|
artikel
|
| 6 |
Editorial
|
Kaufmann, Stefan H.E.
|
|
2008
|
|
1-2 |
p. 1-2
2 p.
|
artikel
|
| 7 |
Engineering of cytomegalovirus genomes for recombinant live herpesvirus vaccines
|
Mohr, Christian A.
|
|
2008
|
|
1-2 |
p. 115-125
11 p.
|
artikel
|
| 8 |
Helicobacter pylori vaccine development: Optimisation of strategies and importance of challenging strain and animal model
|
Hoffelner, Herbert
|
|
2008
|
|
1-2 |
p. 151-159
9 p.
|
artikel
|
| 9 |
Improving live attenuated bacterial carriers for vaccination and therapy
|
Loessner, Holger
|
|
2008
|
|
1-2 |
p. 21-26
6 p.
|
artikel
|
| 10 |
Listeria monocytogenes as novel carrier system for the development of live vaccines
|
Schoen, Christoph
|
|
2008
|
|
1-2 |
p. 45-58
14 p.
|
artikel
|
| 11 |
Mechanisms of dendritic cell-based vaccination against infection
|
Fajardo-Moser, Marcela
|
|
2008
|
|
1-2 |
p. 11-20
10 p.
|
artikel
|
| 12 |
Rational design of Salmonella recombinant vaccines
|
Cheminay, Cédric
|
|
2008
|
|
1-2 |
p. 87-98
12 p.
|
artikel
|
| 13 |
Rational design of vaccines against tuberculosis directed by basic immunology
|
Reece, Stephen T.
|
|
2008
|
|
1-2 |
p. 143-150
8 p.
|
artikel
|
| 14 |
Recombinant coxsackievirus vectors for prevention and therapy of virus-induced heart disease
|
Henke, Andreas
|
|
2008
|
|
1-2 |
p. 127-134
8 p.
|
artikel
|
| 15 |
Salmonella type III-mediated heterologous antigen delivery: A versatile oral vaccination strategy to induce cellular immunity against infectious agents and tumors
|
Panthel, Klaus
|
|
2008
|
|
1-2 |
p. 99-103
5 p.
|
artikel
|
| 16 |
Structural requirements for uptake and recognition of CpG oligonucleotides
|
Heeg, Klaus
|
|
2008
|
|
1-2 |
p. 33-38
6 p.
|
artikel
|
| 17 |
The FAI protein of group C streptococci acts as a mucosal adjuvant by the specific targeting and activation of B cells
|
Schulze, Kai
|
|
2008
|
|
1-2 |
p. 3-10
8 p.
|
artikel
|
| 18 |
Vaccine protocols for enhanced immunogenicity of exogenous antigens
|
Heit, Antje
|
|
2008
|
|
1-2 |
p. 27-32
6 p.
|
artikel
|
| 19 |
Yersinia as oral live carrier vaccine: Influence of Yersinia outer proteins (Yops) on the T-cell response
|
Trülzsch, Konrad
|
|
2008
|
|
1-2 |
p. 59-67
9 p.
|
artikel
|
| 20 |
Yersinia enterocolitica: Subversion of adaptive immunity and implications for vaccine development
|
Autenrieth, Stella E.
|
|
2008
|
|
1-2 |
p. 69-77
9 p.
|
artikel
|
Tijdschrift beschrijving